Importation

Twenty-Four States Passed 37 Bills to Curb Rising Rx Drug Costs in the Short 2018 Legislative Session

Despite a short legislative season, state lawmakers across the country introduced an unprecedented 160 bills to stem the rising cost of prescription drugs and have enacted 37 into law — with seven state legislatures still in session. Last year, state legislatures introduced 100 Rx cost control bills and passed 27. Register Now to Attend NASHP’s […]

Read More
  • A Glossary of All Terms Pharma

    If you’re working to control the cost of prescription drugs, you need to know the lingo used by the pharmaceutical industry. Below is a glossary of terms commonly used by players in the drug research, regulation, manufacturing, distribution, and purchasing worlds. Drug Product Terms Brand product: Branded products are not generic drugs or products. A brand can be […]

    Read More
  • Vermont First in the Nation to Approve Rx Drug Importation from Canada

    Vermont is the first state  in the nation to approve importation of less-costly prescription drugs from Canada. For the first time in the United States, obtaining low-cost prescription drugs from Canada is one step closer to reality today following the Vermont state legislature’s landmark enactment of S.175. Vermont Gov. Philip Scott signed the bill into law on […]

    Read More
  • Four More States Submit Bills to Import Prescription Drugs from Canada
    State Health Policy Blog

    As states pursue a wide range of legislation to address rising drug costs, four more states have joined Utah and Vermont to introduce bills to import prescription drugs from Canada through a state-run, wholesale operation. This market-based approach to providing more affordable medicines from Canada, where prescription drugs cost on average 30 percent less than […]

    Read More
  • State Legislatures Start Out Strong in 2018 with Bills to Curb Rx Drug Costs
    State Health Policy Blog

    With the federal government continuing to take no action to curb drug costs, states legislatures across the country are intensifying their efforts in 2018 to staunch the financial hemorrhage to health care budgets caused by escalating prescription drug costs. Three weeks into 2018, 43 bills designed to rein in prescription drug costs have been introduced […]

    Read More
  • State Legislative Action to Lower Pharmaceutical Costs
    Maps

    *Updated June 22, 2018* Find the status of state legislation to curb prescription drugs below. Use the category button to search for a type of legislation or click on a state to view its drug bills. Click here to view a chart listing legislation by state. Click to view state legislative action in 2017 and 2015-2016. Know about a […]

    Read More
  • Utah State Legislator Introduces Bill to Import Prescription Drugs from Canada, Based on NASHP Model Legislation

    Salt Lake City, Utah: Today, Republican state legislator Norman Thurston introduced groundbreaking legislation to create a safe, state-run prescription drug importation program that would import high-cost drugs from Canada, where prescription drugs cost 30 percent less than in the United States. The proposal for a whole-sale importation program of select, higher-cost drugs that are already […]

    Read More
  • Reining in Rx Drug Costs: What States Achieved in 2017 and Where They’re Heading in 2018
    State Health Policy Blog

    In a year of tense partisan debate over the future of health care, one issue has achieved rare bipartisan agreement — the need to curb rising prescription drug costs. Polls show again and again that Americans, regardless of political affiliation, view the high costs of drugs as one of their chief health care concerns. Reviews […]

    Read More
  • Is It Safe and Cost-Effective to Import Drugs from Canada?

    States are considering importing prescription drugs from Canada, but is it safe, will it save money, and can it be done? Three, easy-to-read infographics explain what state leaders need to know if they’re considering drug importation legislation. First, 40 percent of all drugs sold in the United States are already imported and 80 percent of […]

    Read More
  • Publications

    When states pass laws designed to control prescription drug costs, the pharmaceutical industry often responds with lawsuits claiming states are hindering interstate commerce and violating the federal Dormant Commerce Clause (DCC). NASHP’s legal experts believe states can craft drug cost policies that can withstand industry challenges. This brief by Anna Zaret and Darien Shankse provides insight and […]

    Read More